Curtains raised for pharma ingredients show CPhI in Mumbai

With over 1000 plus exhibitors from 95 countries, pharma ingredients exhibition CPhI – along with other concurrent events P-MEC, ICSE and BioPh India – is likely to offer global pharma industry an opportunity to explore India as destination for sourcing and consumption, claims the organiser of the event, UBM India. Being held from December 3-5, 2013, in Mumbai, the event is expected to be attended by nearly 30,000 attendees from 109 countries.
 
Commenting on the inauguration, Joji George, Managing Director, UBM India highlighted the unprecedented interest on India by global pharma industry. He stated, “It is no longer that India is considered as a mere destination of low-cost manufacturing and low-end bulk drugs. The profiles of international participants reflect that everyone from every known market across the globe is interested in India. Everyone is so keen to leverage CPhI & P-MEC India this year to grab the opportunity. It is the bus that no one wants to miss.”
 
ALSO READ: Pharma industry needs to adjust to attract and retain Gen Y

UBM also launched India Pharma Awards – an initiative to celebrate the thinkers and creators from the pharma sector who constantly innovate and break new ground at every stage of the value chain. Desh Bandhu Gupta, Chairman, Lupin Laboratories was presented with the Lifetime Achievement Award, and Vijay Kumar Ambati, President and CEO, Clearsynth, was conferred with Emerging Entrepreneur of the Year award.
 
Speaking at the UBM India Pharma Awards, Satej D Patil, MoS, Home (Urban & Rural), Rural Development, Food & Drug Administration, said, “Over the years, pharma companies have grown inorganically through acquisitions, but due to higher valuations seen in the sector over the last two years, they have been exploring newer methods of partnerships such as joint ventures and licensing of innovator products and technologies. Companies are focusing on improving operational efficiencies, which have yielded results. Going forward, India should leverage its strengths in the supply of low-cost, quality medicines across the world and play a larger role in the global pharma market.”